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Abstract
Aims: Expression of Heat Shock Protein-27 (HSP27) is reduced in human coronary atherosclerosis. Over-expression of HSP27
is protective against the early formation of lesions in atherosclerosis-prone apoE2/2 mice (apoE2/2HSP27o/e) - however,
only in females. We now seek to determine if chronic HSP27 over-expression is protective in a model of advanced
atherosclerosis in both male and female apoE2/2 mice.
Methods and Results: After 12 weeks on a high fat diet, serum HSP27 levels rose more than 16-fold in male and female
apoE2/2HSP27o/e mice, although females had higher levels than males. Relative to apoE2/2 mice, female apoE2/2HSP27o/e
mice showed reductions in aortic lesion area of 35% for en face and 30% for cross-sectional sinus tissue sections – with the
same parameters reduced by 21% and 24% in male cohorts; respectively. Aortic plaques from apoE2/2HSP27o/e mice
showed almost 50% reductions in the area occupied by cholesterol clefts and free cholesterol, with fewer macrophages and
reduced apoptosis but greater intimal smooth muscle cell and collagen content. The analysis of the aortic mechanical
properties showed increased vessel stiffness in apoE2/2HSP27o/e mice (41% in female, 34% in male) compare to apoE2/2
counterparts.
Conclusions: Chronic over-expression of HSP27 is atheroprotective in both sexes and coincides with reductions in lesion
cholesterol accumulation as well as favorable plaque remodeling. These data provide new clues as to how HSP27 may
improve not only the composition of atherosclerotic lesions but potentially their stability and resilience to plaque rupture.
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Introduction
Heat Shock Protein 27 (HSP27) is a member of the small heat
shock protein family and is involved in a wide variety of cellular
processes, both physiological and pathological. Originally de-
scribed as an intracellular chaperone, HSP27 is capable of binding
and stabilizing the actin cytoskeleton in response to stress as well as
preventing downstream caspase activation [1]. More contempo-
rary studies now show that HSP27 and other (unrelated) heat
shock proteins may have an extracellular role and signal via
discrete receptors [2]. Indeed, we recently demonstrated that, via
NF-kB activation, extracellular HSP27 regulates the expression of
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a number of genes, including several of direct relevance to
regulation of vessel wall inflammation [3].
The expression of HSP27 in atherosclerotic plaques diminishes
with progression of the stage of the pathology [4,5]. Moreover,
serum levels of HSP27 are reduced in patients with carotid artery
disease [5] yet are increased in acute coronary syndromes [6].
Decreased HSP27 expression may be an important factor in the
development of atherosclerosis; hence to address this question we
performed acute studies of atherosclerosis-prone apoE2/2 mice
that over-express HSP27 (i.e., apoE2/2HSP27o/e) [7]. After four
weeks of ingesting a high fat diet (HFD) there was approximately a
35% reduction in the extent of aortic atherosclerosis in apoE2/2
HSP27o/e relative to apoE2/2 mice – but only in females. There
are several important findings from our original atherogenesis
studies involving apoE2/2HSP27o/e mice. First, while baseline
serum levels of HSP27 are virtually undetectable in all mice (prior
to ingesting a HFD), there was a .10-fold increase in serum
HSP27 levels in female apoE2/2HSP27o/e mice after 4 weeks of
HFD but practically no change in male counterparts. Second, in
female apoE2/2HSP27o/e mice there was an inverse correlation
(r2 = 0.78) between HSP27 levels and extent of atherosclerotic
burden. Third, sex-specific in vivo atheroprotection coincided with
our in vitro demonstration that the release of HSP27 from
macrophages occurs in response to estrogens. Finally, we
subsequently demonstrated that ovariectomized apoE2/
2HSP27o/e mice do not show elevated serum HSP27 levels or
atheroprotection until they are given estrogen replacement
therapy [8]. However, it is important to note that, in addition to
estrogens promoting the release of HSP27 into the extracellular
space, we previously observed in vitro that acLDL did so as well.
Hence, the question remains – could chronic exposure to an
atherogenic diet that is enriched in cholesterol promote the release
of HSP27 into the serum (and therefore atheroprotection) in male
mice – but perhaps requires higher serum levels of cholesterol
and/or more chronic exposure (.4 weeks) to be detectable?
In anticipation of future studies designed to explore the
potential of HSP27 as a novel therapeutic agent (e.g., recombinant
HSP27 protein), we sought to determine if over-expression of
HSP27 is chronically atheroprotective and alters not only plaque
burden but also morphology as reflected by a unique assessment of
both the histology and mechanical properties of aortic lesions.
Briefly, we now demonstrate that chronic HSP27 over-
expression attenuates atherogenesis in both males and females
and is accompanied not only by reductions in lesions size but also
arterial wall cholesterol content, macrophages accumulation and
apoptosis. Moreover, we note that the aortae of these mice show
increased intimal smooth muscle cell and collagen content as well
as increased vessel stiffness. This study provides new evidence that
the atheroprotective effect of HSP27 results not only in reduced
plaque burden but also an enhanced histo-mechanical profile of
lesions.
Methods
Murine atherosclerosis model
All experimental procedures involving laboratory animals were
approved by the Animal Care and Use Committee of the
University of Ottawa and complied with the United States
National Institute of Health Guide for the Care and Use of
Laboratory Animals. Transgenic mice with a C57BL10/CBA
background and over-expressing human heat shock protein 27
(HSP27o/e) under the control of a chicken b-actin promoter and a
CMV enhancer element were provided by Imperial College
London. ApoE2/2 mice with the C57BL/6 genetic background
were purchased from the Jackson Laboratory (Bar Harbor,
Maine). HSP27o/e females were crossed with apoE2/2 males to
generate apoE+/2HSP27o/e mice, which were then crossed with
apoE2/2 mice to generate apoE2/2HSP27o/e and apoE2/2
littermates [7,9]. Each study cohort consisted of at least six mice.
Mice were fed a normal chow diet until 6 weeks of age and
thereafter received a high-fat diet (HFD, 1.25% cholesterol, 15.8%
fat; Harlan Teklad, Madison, WI) for 12 weeks until euthanasia
when blood samples were collected (Figure 1A). Depending on
the nature of the intended experiment, the aortae were harvested
as follows. For histological evaluations, animals were anaesthetized
under isoflurane, and whole blood was collected via cardiac
puncture before systemically perfusing the mice via the left
ventricle with phosphate-buffered saline (PBS) followed by 4%
paraformaldehyde (PFA) in PBS, before the heart and aorta were
removed and immersed in 4% PFA/PBS at 4uC overnight. To
quantify the aortic mechanical properties, the heart and aorta
were immediately removed after euthanasia and immersed in
Krebs solution (118.1 mM NaCl, 11.1 mM D-glucose, 25 mM
NaHCO3, 4.7 mM KCl, 1.2 mM MgSO4N7H2O, 1.2 mM
KH2PO4, 2.5 mM CaCl2N6H2O, pH: 7.4) at 37uC and immedi-
ately processed.
Hemodynamic parameters
Hemodynamic parameters (heart rate, systolic and diastolic
blood pressure) were measured using a tail-cuff system (BP-2000
Blood Pressure Analysis System, Visitech Systems) in conscious
animals. To obtained stable values, mice were preconditioned for
three consecutive days (morning and afternoon) and hemodynam-
ic parameters were recorded during the subsequent two days
(morning).
Serum Cholesterol and HSP27 Measurements
An enzymatic assay kit (Wako Pure Chemical Industries, Ltd,
Osaka, Japan) was employed to determine serum levels of total
cholesterol. Serum HSP27 levels were measured using an ELISA
kit specific to human HSP27 (QIA119, Calbiochem, San Diego,
CA).
Preparation of the aorta and evaluation of atherosclerosis
Each aorta was dissected from the ascending to the thoracic
segments and the adventitial connective tissue was removed from
each segment before it was pinned to a black wax surface using
micro-needles and photographed. Thereafter, the aorta was
opened longitudinally with the primary incision following the
lesser curvature of the arch. To obtain a flat preparation for
imaging, a second incision was made along the greater curvature
of the arch down to the level of the left subclavian artery. Lipid-
rich intraluminal lesions were stained with oil red O and
photographed. The en face aortic atherosclerotic lesions were
analyzed by two observers using Image-Pro software (Media
Cybernetics, Silver Spring, MD) to calculate the total and
atherosclerotic lesion areas. As described previously the extent of
atherosclerosis was expressed as the percentage of surface area of
the entire aorta covered by lesions [7].
Assessment of atherosclerosis in the aortic sinus
The superior half of the heart including the aortic root was
embedded in paraffin or frozen in Tissue-Tek O.C.T. media.
Serial 4 mm sections of the aortic sinus with valves were cut,
beginning at the level where the aortic valve first appears, and
stained with hematoxylin and eosin (H&E), Masson’s trichrome,
oil red O and filipin. Additional tissue sections were used for an
HSP27 Alters Atherogenesis
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apoptosis assay and supplementary immunohistochemical/immu-
nofluorescence labeling. For the quantification of atherosclerotic
lesion areas all micrographs were captured with a bright field/
fluorescence microscope (Olympus BX60; Olympus America Inc.,
Center Valley, PA) and analyzed by two observers using Image-
Pro software. Lesion area data for each mouse is presented as the
mean lesion area of four sections.
Quantification of cholesterol crystal clefts in
atherosclerotic lesions
H&E and Masson’s trichrome stained serial sections were
employed for assessment of cholesterol crystal deposition in
atherosclerotic lesions. Cholesterol clefts were defined as ghost-
like needle-shaped spaces that resulted from dissolution of
cholesterol crystals during paraffin-embedding and tissue process-
ing. In addition, the necrotic area was defined by the presence of
pyknosis, karyorrhexis, or complete absence of nuclei. The
cholesterol cleft and necrotic areas were measured using morpho-
metric analysis, as described previously [10].
Combination of filipin and oil red O staining on the same
tissue section
To observe both un-esterified cholesterol and lipoid deposits
within the same tissue section, the fluorescent polyene antibiotic
filipin and the lipid-soluble dye oil red O were respectively
employed according to previously described methodologies [11].
Briefly, a 4 mm-thick cryostat section was incubated in oil red O
solution (Sigma; St. Louis, MO) for 1 hour at room temperature.
Following washes in PBS, the section was stained with hematox-
ylin. After repetitive washing in PBS the section was treated with
the filipin solution (Sigma) for 2 hours at room temperature.
Triplicate washes in PBS were again performed before mounting
in 50% glycerol in PBS. Fluorescence was viewed through a
D405 nm (blue) and D490 nm (green) barrier filter, respectively.
Photomicrographs were taken under the fluorescence exposure
followed by bright field using an Olympus BX60 microscope.
Quantification of macrophage and smooth muscle cell
content in atherosclerotic lesions
Macrophage content was assessed using the avidin-biotin-
alkaline phosphatase method (Vector Laboratories, Burlingame,
California, USA) as described previously [12]. Briefly, tissue
sections were pre-incubated with 10% normal horse serum in PBS
for 5 minutes followed by a rat anti-mouse macrophage primary
antibody (Mac-2; Accurate Chemical and Scientific Corp.,
Westbury, New York, USA) diluted in PBS 1:500 at 4uC
overnight. After repetitive rinsing with PBS, the sections were
incubated with a biotinylated rabbit anti-rat secondary antibody
(1:100, Vector Laboratories, Burlingame, California, USA) for
10 minutes at room temperature. The endogenous peroxidase was
quenched with 3% H2O2 for 10 minutes. Antibody reactivity was
detected using an ABC kit (Vector Laboratories, Burlingame,
California, USA) and visualized with diaminobenzidine (DAB)/
hydrogen peroxidase as chromogenic substrate, resulting in a
brown-colored precipitate at the antigen site. As a negative
control, tissue sections from each mouse were subjected to the
same immunohistochemical protocols but in the absence of the
primary antibody. Sections were counterstained with hematoxylin
to identify the nucleus, cleared, and mounted. To immunolabel for
smooth muscle cell (SMC) content tissue sections were blocked
with 10% normal horse serum before being incubated with an
mouse anti-a-smooth muscle actin alkaline phosphatase conjugat-
ed antibody (aSMA; Sigma, Saint Louis, Missouri, USA) diluted in
PBS 1:60 at 4uC overnight. The visualization of a positive
immunoreaction was made possible by the addition of the SIGMA
FAST Fast Red TR/Naphthol AS-MX Phosphate (4-Chloro-2-
methylbenzenediazonium/3-Hydroxy-2-naphthoic acid 2,4-di-
methylanilide phosphate, Sigma, St. Louis, MO), which resulted
in a red color reaction product. SMC and macrophage areas were
quantified using Image-Pro software according to previously
described techniques [13].
Quantification of apoptotic cells in atherosclerotic lesions
Apoptotic cells in atherosclerotic lesions were observed using an
In Situ Apoptosis Detection Kit (TUNEL, TACS-XL, TA200, R&D
Figure 1. Experimental timeline and physiological parameters. (A) Schematic overview of chronic HSP27 over-expression atheroprotection
experiment in apoE2/2mice. (B) Table profiling the physiological parameters and the 16-fold increase in serum HSP27 levels in male and female mice
maintained on a HFD for 12 weeks.
doi:10.1371/journal.pone.0055867.g001
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Systems, Inc. Minneapolis, MN, USA) and by the detection of
activated Caspase 3 using a Cleaved Caspase 3 antibody (Cell
Signaling Technology, Inc. Danvers, MA, USA). For TUNEL
staining, serial 4 mm sections were incubated with 20 mg/ml
proteinase K for 20 minutes at room temperature and washed in
PBS. Endogenous peroxidase activity was squelched by incubating
with 3% H2O2 for 10 minutes, washing with PBS and then
incubated in 16TdT Labeling Buffer for 5 minutes at room
temperature. Sections were treated with the Labeling Reaction
Mix for 1 hour at 37uC and then soaked in 16TdT Stop Buffer for
5 minutes at room temperature. Following triplicate washes in
PBS sections were incubated with an anti-BrdU antibody for
1 hour at 37uC. After triplicate washes sections were covered with
a horseradish peroxidase streptavidin solution for 30 minutes at
room temperature. The sections were then washed with PBS and
treated with 0.03% 3,39-diaminobenzidine (DAB) containing
0.01% H2O2 in order to visualize the immunolabeling. Sections
were counterstained with hematoxylin to identify the nucleus,
cleared and mounted. For negative controls, the Labeling
Reaction Mix was omitted. Tissue sections were examined using
an Olympus BX60 microscope equipped with a high-resolution
digital camera. In each section, the total intimal cell number and
TUNEL-positive apoptotic cells within the intima (excluding the
necrotic core regions) were manually counted and expressed as the
percentage of intimal cells that are TUNEL-positive. For Cleaved
Caspase 3 staining, serial 4 mm sections were treated with 0.01 M
citric acid buffer (pH 6.0) for 3 minutes in microwave, and then
pre-incubated with 10% normal horse serum in PBS for 5 minutes
and the sections were incubated with a rabbit anti-Cleaved
Caspase 3 antibody diluted in PBS 1:100 at room temperature for
1 hour. After repetitive rinsing with PBS, the section was
incubated with a Texas red goat anti-rabbit secondary antibody
(1:100, Vector Labs) at room temperature for 30 minutes.
Following triplicate washes in PBS, tissue sections were incubated
with Hoechst 33258 to produce a nuclear signal. Three washes
with PBS were again performed before mounting in 50% glycerol
in PBS. Photomicrographs were obtained using a fluorescence
microscope (Olympus, BX60).
Combination of immunofluorescence and histochemistry
in same tissue section
In order to clearly interpret the morphological relationships
amongst various cells and their environments, both immunoflu-
orescence and histochemistry were applied on the same section as
described previously [14]. Briefly, in addition of TUNEL and
Cleaved Caspase 3 labeling, tissue sections were also label with
aSMA/Mac-2 immunolabeling and H&E staining. Tissue sections
were pre-incubated with 10% normal horse serum in PBS for
5 minutes followed by a mouse anti-aSMA-FITC (Sigma, Saint
Louis, Missouri, USA) diluted in PBS 1:1000 or a rat anti-mouse
Mac-2 (Accurate Chemical and Scientific Corp., Westbury, New
York, USA) diluted in PBS 1:500 at room temperature for 1 hour.
After repetitive rinsing with PBS, the section was incubated with a
biotinylated rabbit anti-rat secondary antibody (1:100, Vector
Laboratories, Burlingame, California, USA) for 10 minutes at
room temperature and assessed as described previously or a Texas
red goat anti-rat antibody (1:100, Vector Laboratories Inc.
Burlingame, CA) for 30 minutes at room temperature. Following
triplicate washes in PBS tissue sections were incubated with
Hoechst 33258 to produce a nuclear signal. Three washes with
PBS were again performed before mounting in 50% glycerol in
PBS. Photomicrographs were obtained using a fluorescence
microscope (Olympus, BX60). Thereafter, the same section was
washed with PBS and subjected to hematoxylin staining, and
repeat photomicrographs were obtained.
Quantification of Collagen Content
Picro-sirius red (Sigma) was used to stain for collagen [15,16].
Co-aligned molecules of Type I collagen display a bright yellow or
orange birefringence with polarized microscopy. Image Pro
software was used to quantify the intimal collagen content, and
the result was expressed as a percentage of the total intimal area.
Evaluation of aortic stiffness
The effect of HSP27 over-expression on aortic stiffness was
assessed using a custom made vessel-stretching device. The vessel
dimensions and the force required to stretch a 2 mm aortic ring
segment were used to compute the stress induced in the vessel wall
and to calculate the stiffness of the thoracic aortic segments. The
motorized stage uses a linear voice coil motor (Moticont, CA,
USA) mounted on a miniature linear motion ball bearing slide
(Edmund Optics Inc., NJ, USA). The real-time position of the
motorized stage was recorded using an optical encoder with a
resolution of 0.5 mm (MicroE Systems, MA, USA). The motor was
controlled with a motion controller (DMC-2143, Galil, CA, USA)
fed by the output signal of the optical encoders to execute motion
commands. Motion commands are managed using a LabVIEW
interface (National Instruments, TX, USA), which controls
displacement and speed of the stage. Force was measured using
a miniature load cell (model 31 low) with a load range of 0–150 g
(Honeywell, MN, USA). Displacement and force measurements
were acquired simultaneously using a data acquisition card
interfaced with LabVIEW.
The load cell is kept fixed in space while the motorized stage is
allowed to move and induce tissue stretch. Hooks are aligned
together for mounting of an aortic ring. All samples were kept in
Krebs solution at 37uC during stretching experiments. The system
was automated to induce a 40% stretch based on the unloaded
dimensions of each aortic ring. The tissues were subjected to 12
loading and unloading cycles with a displacement rate of 50 mm/s.
The first 11 cycles served to precondition the tissue (40% stretch)
and the final cycle was considered as the experimental run. Each
aortic ring generated a force-stretch curve. Force data were
transformed into engineering stress by dividing the force by the
length of the tissue and its thickness. Tissue stiffness was quantified
using a MATLAB script (MathWorks, Massachusetts, USA),
which calculates the slope of each stress-stretch curve at 30% of
stretch.
Statistical Analysis
All data represent the mean 6 standard error of the mean
except as specifically stated. Statistical analyses were performed
with one-way ANOVA by using SigmaStat 3.5 software. A value
of p,0.05 was considered statistically significant.
Results
All mice thrived during these experiments (Figure 1A) and
body weights were similar between the cohorts, though males were
consistently ,30% heavier than females (Figure 1B). The
hemodynamic parameters (systolic, diastolic, mean blood pressure
and heart beat) of the apoE2/2 and apoE2/2HSP27o/e mice
cohorts at 12 weeks after the beginning of the HFD were similar.
Total serum cholesterol levels rose in all groups and were similar in
female mice at euthanasia (apoE2/2: 1,1446198 vs. apoE2/2
HSP27o/e: 1,4056217 mg/dl; p=ns). However, in male mice the
total serum cholesterol levels at euthanasia were lower in the
HSP27 Alters Atherogenesis
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apoE2/2HSP27o/e compared to apoE2/2 mice (1,4976304 vs.
1,8326267 mg/dl; p,0.05). In mice of both sexes serum HSP27
levels rose by more than 16-fold from baseline until completion of
a 12 week HFD/euthanasia, however both baseline and final levels
were higher in females compared to males (e.g., females: 2116116
to 3,47361,340 pg/ml, p=0.02; males: 74623 to 1,2046473 pg/
ml, p=0.04) (Figure 1B).
HSP27 over-expression reduces aortic atherosclerotic
lesion area
Female apoE2/2HSP27o/e mice showed reductions in aortic
lesion area of 35% for en face and 30% for cross-sectional sinus
tissue sections compared to apoE2/2 female counterparts
(p,0.001 for both). Male apoE2/2HSP27o/e mice also showed
reductions in aortic lesion area of 21% in the en face and 24% for
cross-sectional sinus sections compared to their apoE2/2 male
counterparts (p,0.001 for both) (Figure 2).
HSP27 over-expression reduces aortic lesion cholesterol
content
Within the necrotic core of atherosclerotic lesions the acellular
area containing cholesterol clefts was reduced in apoE2/
2HSP27o/e mice by 28% and 42% in females and males
compared to their apoE2/2 counterparts (p,0.05 and p,0.001
respectively; Figure 3A, B). As well, the intimal lipid and free
cholesterol content, as reflected by oil red O (Figure 3C) and
filipin staining (Figure 3D), respectively, were lower in apoE2/
2HSP27o/e mice compared to apoE2/2 mice.
HSP27 over-expression and lesion macrophage content
and remodeling
Previously we demonstrated that HSP27 over-expression results
in reduced macrophage adherence and migration in vitro [7]. As
macrophage apoptosis is a prominent characteristic of atheroscle-
rotic plaques (see review, [17]) and HSP27 is a known anti-
apoptotic factor [18], we postulated that HSP27 over-expression in
vivo would result in reduced plaque macrophage content and
apoptosis. The aortic sinus cross-sectional area occupied by
macrophages was identified using an anti-macrophage antibody
(Mac-2) and quantified (Figure 4A). Macrophage content in the
lesion area was reduced by 38% and 26% in female and male
apoE2/2 HSP27o/e mice, respectively, when compared to their
apoE2/2 counterparts (Figure 4B, p,0.01 & p,0.05; respec-
tively). Apoptotic macrophages were identified in lesions using a
combination of TUNEL and Mac-2 immunolabeling. TUNEL-
positive cells within the nuclei of Mac-2-immunopositive macro-
phages were found surrounding (Figure 4C) as well as within the
necrotic core of aortic lesions (data not shown). In the non-necrotic
core the percentage of apoptotic cells found in aortic lesions were
reduced by approximately 35% and 55% in female and male
apoE2/2HSP27o/e compared to control sex-matched apoE2/2
mice (Figure 4D, p,0.05 & p,0.001; respectively). In order to
clarify if vascular smooth muscle cells apoptosis is also present in
lesion, we performed double immunohistochemistry/immunoflu-
orescence studies with TUNEL and cleaved Caspase 3
(Figure 4E, F). We demonstrate that apoptosis is present in
lesions but is primarily found in the necrotic core and did not co-
localize with VSMCs.
HSP27 over-expression and lesion SMC/Collagen content
The aortic sinus cross-sectional area occupied by SMCs was
identified using anti-SMC immunolabeling and quantified
(Figure 5A, B). SMC content in the lesion area was increased
by 72% and 127% in female and male apoE2/2 HSP27o/e mice,
respectively, when compared to their apoE2/2 counterparts
(p,0.05 for both). Enhanced intimal collagen content is purported
to represent a surrogate marker for lesion resilience to plaque
Figure 2. HSP27 over-expression reduces aortic atherosclerotic
lesion area in female and male mice. (A) The aortic atherosclerotic
lesion area was analyzed in apoE2/2HSP27o/e mice and compared to
apoE2/2 littermates. We observed a reduced lesion area in the aortic
wall (B) and in the aortic sinus (C) in apoE2/2HSP27o/e compared to
apoE2/2 mice.
doi:10.1371/journal.pone.0055867.g002
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rupture [19]. Using polarized microscopy on picro-sirius red
stained sections we noted that the abundance of collagen was
greater in apoE2/2HSP27o/e compared to apoE2/2 mice.
Indeed, collagen content in the lesion area was increased by
59% and 50% in female and male apoE2/2 HSP27o/e mice,
respectively, when compared to their apoE2/2 counterparts (e.g.,
females: 14.363.9% vs. 9.064.6%, p,0.05; males: 12.865.4% vs.
8.662.7%, p,0.05; Figure 5C, D). Finally, we noted a direct
relationship between the abundance of intimal collagen and SMC
area in lesions (R2 = 0.421, p,0.001; Figure 5E).
HSP27 over-expression increases aortic stiffness
To determine the impact of the enhanced intimal collagen
content on the vessel mechanical properties, 2 mm aortic ring
segments were precisely measured and preconditioned in prepa-
ration for stretching experiments (Figure 6A–D). The overall
aortic wall thickness of equivalent segments from both murine
cohorts was similar (e.g., apoE2/2: 128.969.3 mm; apoE2/
2HSP27o/e: 124.566.8 mm). Changes in the vessel stiffness
induced by the over-expression of HSP27 were determined by
the calculation of the Young’s modulus (Pa) from the stress-strain
curves generated during the stretching experiment. The stiffness of
the aortic segments in female and male apoE2/2 mice were
44.463.8 kPa and 50.562.2 kPa, respectively and in the same
order of magnitude as the stiffness of human tissues that we
previously reported [20]. In contrast chronic over-expression of
HSP27 resulted in 41% and 34% increases in aortic stiffness (e.g.,
62.863.0 kPa in females and 67.961.9 kPa in males; p,0.001 for
both groups, Figure 6E).
Discussion
Previously we showed that HSP27 over-expression reduced
atherogenesis in female but not male apoE2/2HSP27o/e mice fed
a HFD for 4 weeks. We also noted a tight inverse correlation
between aortic atherosclerotic lesion burden and serum HSP27
levels [7]. In the current study we sought to determine if long-term
over-expression of HSP27 attenuates atherogenesis independent of
sex. Herein, we found that after 12 weeks on HFD, serum HSP27
levels rose in both male and female apoE2/2 HSP27o/e mice.
Moreover, both male and female apoE2/2 HSP27o/e mice show
reduced aortic lesion burdens, with important reductions in plaque
cholesterol and macrophage accumulation, as well as increased
intimal collagen content and aortic stiffness.
Several important concepts emerge from the current study.
First, both sexes of apoE2/2HSP27o/e mice showed a more than
16-fold increase in HSP27 serum levels. Female apoE2/2HSP27o/e
mice had higher baseline and final serumHSP27 levels compared to
males. Indeed, male apoE2/2HSP27o/e mice had serum HSP27
levels that are similar to those previously observed in female apoE2/
2HSP27o/e mice after ingesting a HFD for just 4 weeks [7]. These
higher serum levels of HSP27 in the female mice correlate with
important earlier observations from our laboratory. Previously we
demonstrated in vitro that estrogens promote the extracellular release
Figure 3. HSP27 over-expression reduces aortic lesion cholesterol content. (A–B) Cholesterol cleft area is reduced within lesions from
apoE2/2HSP27o/e vs. apoE2/2 mice as observed using the Masson’s trichrome stain. (C) Reduction in arterial wall cholesterol content with over-
expression of HSP27 with oil red O staining identifying lipid deposits. (D) Attenuated arterial wall unesterified cholesterol content in apoE2/2HSP27o/e
mice as denoted by fluorescent blue filipin staining. Scale bar= 100 mm (A, C and D) and 500 mm (inserted photo of A), L = lumen.
doi:10.1371/journal.pone.0055867.g003
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of HSP27 from macrophages, and that in vivo HSP27 over-
expression in ovariectomized mice requires estrogen replacement
therapy to restore both the rise in serum HSP27 levels and
atheroprotection that normally occurs when these mice are placed
on a HFD [7,8]. Presumably the rise in serum HSP27 levels seen in
the male mice from the current study is the result of prolonged
Figure 4. Reduction in arterial wall foamy macrophage content and apoptosis with over-expression of HSP27. (A) Macrophages
(brown anti-Mac-2 immunolabeling reaction product) localized mainly in layers along the lumenal surface of aortic sinus cross-sections. (B)
Quantification of macrophage content in aortic sinus cross-sections. (C) On a single tissue section stained for histomorphology (hematoxylin and
eosin stain; H&E), an apoptotic cell (TUNEL labeling in nucleus; green/arrow) immunolabeled with an anti-Mac-2 macrophage antibody (red
immunofluorescence) is identified. (D) Quantification of apoptotic cells in aortic sinus cross-sections. (E, F) Combination of immunohistochemical
and fluorescent TUNEL/Cleaved Caspase 3 staining demonstrating that apoptosis is detected in lesions but do not involve vascular smooth muscle
cells. In (E), TUNEL (green), aSMA (red), Mac-2 (brown) and Hoechst (blue). In (F), cleaved Caspase 3 (red), aSMA (green) and Hoechst (blue). Scale
bar = 100 mm (A, F), 500 mm (inserted photo of A), 10 mm (C) and 50 mm (E). L = lumen, I = Intima, M=Media, dotted lines delineates the media.
doi:10.1371/journal.pone.0055867.g004
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Figure 5. Increased intimal SMC and collagen content with HSP27 over-expression. (A) SMC (anti-a-SMA red immunolabeling reaction
product) localized mainly in sub-endothelial layers along the luminal surface of aortic sinus cross-sections. (B) Quantification of SMC content in aortic
sinus cross-sections. (C) Intimal collagen content demonstrated by polarized microscopy. Bright yellow or orange birefrigence of collagen, due to co-
aligned molecules of Type I collagen. (D) Quantification of intimal collagen content. (E) Correlation between collagen and SMC content in lesions.
Scale bar in (A) and (C) = 20 mm and 200 mm (insert photo), L = Lumen, I = Intima, dotted lines delineates the media.
doi:10.1371/journal.pone.0055867.g005
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exposure to the metabolic influences of an atherogenic HFD – as
before we noted in vitro that macrophages treated with acLDL also
secreted HSP27 [7]. Detecting HSP27 levels in the serum is a recent
phenomenon, as HSPs are traditionally considered as intra-cellular
chaperone proteins – yet an expanding number of HSPs are now
identified in the extracellular space and implicated in macrophage
signaling events (see review, [21]). While our understanding of the
mechanisms by which HSPs exit cells is incomplete, we demon-
strated that the release of HSP27 from macrophages occurs via an
exosomal pathway [8].
Second, it is intriguing to consider why HSP27 over-expression
is associated with a reduction in plaque cholesterol cleft area and
lipid content. In a previous study, we showed that extracellular
HSP27 interacts with Scavenger Receptor-A (SR-A) and compet-
itively inhibits the uptake of acLDL in vitro by 41% [7]. Hence, we
have reason to believe that HSP27 interferes with cholesterol
uptake by macrophages, and our recent studies suggests that
HSP27 reduces SR-A expression and the ability of cells to take-up
cholesterol [22].
Third, in the current study we observed an important reduction
in the macrophage content of lesions. Previously we noted in vitro
that adhesion and migration is attenuated in macrophages derived
from apoE2/2HSP27o/e compared to apoE2/2 mice [7]. Yet,
macrophage abundance in lesions is not only determined by the
Figure 6. HSP27 over-expression results in increased aortic stiffness. Aortic stiffness measured in apoE2/2 and apoE2/2HSP27o/e mice fed a
high fat diet for 12 weeks. (A) The custom made vessel-stretching device is composed of a motorized stage with a linear voice coil motor used to
perform loading and unloading cycles. (B–C) To determine the stress applied to vessels during stretching, we measured the unloaded vessel area by
the microscopic measurement of aortic ring segments length (B) and wall thickness (C). (D) The aortic rings were slipped on two parallel hooks and
immersed in a physiological Krebs solution maintained at 37uC. (E) Male and female apoE2/2HSP27o/e mice showed an increase of aorta stiffness
compared to apoE2/2 counterparts.
doi:10.1371/journal.pone.0055867.g006
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number of macrophages that enter lesions – but also by the
survival and exit of macrophages from the plaque. Although
HSP27 is known to have anti-apoptotic effects, despite this
stabilizing effect on macrophage survival, there are still fewer
macrophages in lesions of HSP27 over-expressing mice. At this
stage, we are unable to comment on the dynamics of macrophage
transit from lesions, but we now know that HSP27 dramatically
upregulates GM-CSF, a cytokine known to play an important role
in mononuclear cell trafficking and re-entry into the circulation
[3]. Hence, it is attractive to posit that HSP27 has a stabilizing
effect on vessel wall macrophages, not only reducing their ability to
sequester cholesterol as foam cells, but also reducing their
adherence and entry into lesion, as well as promoting their
survival and potential egress from the plaque.
Fourth, we note that the lesions of HSP27 over-expressing mice
undergo a multi-faceted histological remodeling process that is
consistent with a more resilient lesion. The characteristics of this
lesion remodeling include: i) reduced macrophage content, ii)
reduced apoptotic cells in the non-necrotic areas of lesions, iii)
increased intimal SMC and collagen content, and iv) increased
aortic rigidity. Although we are unable to ascertain a direct
connection between increased SMC and collagen content with the
vessel wall stiffness, these biological changes in the vessel wall are
certainly consistent with the altered mechanical properties that we
measured. It is interesting to note that, while intimal collagen
content was higher for both the female and male apoE2/2
HSP27o/e compared to the apoE2/2 mice, the difference was
greater for males. One possible explanation for the less impressive
increase in collagen content for the female apoE2/2HPS27o/e
mice may be the known negative effect that estrogens have on the
expression of collagen [19]. Certainly, collagen expression is
recognized as an important part of complex human coronary
artery lesions [23]. The abundance of collagen in lesions reflects
the balance between production and destruction. Hence it is
attractive to postulate that the higher collagen content of the
apoE2/2HSP27o/e murine lesions reflects less destruction of
collagen – a possibility that might be predicted from our previous
observations that HSP27 facilitates a shift towards an anti-
inflammatory vascular milieu (e.g., increase in IL-10 with a
decrease in IL-1b) [3,7]. Taken together, these features of vessel
wall remodeling are important surrogate end-points for plaque
resilience and support the contention that HSP27 promotes
favorable vascular remodeling.
Finally, it is interesting to note lower total serum cholesterol
levels in the male apoE2/2HSP27o/e vs apoE2/2 mice. While this
difference in serum cholesterol levels is not found in the female
mice, total serum cholesterol levels are not as high in the female
mice compared to the males. Although the precise mechanistic
explanation for this difference in serum cholesterol levels remains
unclear, we recently identified that HSP27 plays a key role in NF-
kB signaling – including the induction of a number of important
factors that may influence cholesterol levels [3]. Hence, we
speculate that the reduction in serum cholesterol levels observed in
the male apoE2/2HSP27o/e mice may be due to downstream
transcriptional effects (FIGURE 7). Certainly, longer duration
experiments are needed to ascertain if these differences in serum
cholesterol levels become more striking over time and remain
isolated to males.
Taken together, these data indicate that chronic HSP27 over-
expression results in atheroprotection that is independent of sex.
Moreover, HSP27-mediated atheroprotection occurs in associa-
tion with remarkable reductions of plaque lipid and macrophage
abundance plus an increase in intimal collagen content and vessel/
plaques stiffness. While our studies are too short to be conclusive,
we surmise that the enhanced vascular remodeling seen with
HSP27 over-expression may offer an important advantage by
enhancing the resilience of lesions and potentially preventing
plaque rupture. Preliminary therapeutic studies utilizing a
recombinant form of HSP27 are ongoing.
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Figure 7. HSP27 release and cell-signaling. In response to estrogenic stimulation or to atherogenic stress induced by elevated serum cholesterol
levels, HSP27 is released into the extracellular space via an exosomal pathway. Once available in the extracellular space, HSP27 may alter gene
transcription in target cells (e.g., vascular smooth muscle cells or monocyte/macrophages). Shown here is HSP27-induced activation of NF-kB,
resulting in candidate genes expression and the altering of scavenger receptor-A (SR-A) expression, thereby reducing cholesterol uptake and foam
cell formation. The search for a putative HSP27 cell surface receptor is ongoing.
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